PuraPharm Corporation Limited has announced the completion of two significant transactions: a discloseable and connected transaction related to a Patent Licence Agreement, which involved issuing 93,488,372 consideration shares under a specific mandate, and a discloseable transaction regarding the subscription of 46,512,000 new shares by a subscriber, also under a specific mandate. Following these transactions, the company's total issued shares increased to 535,897,647, with the new subscriber holding an 8.68% stake. The transactions are part of the company's ongoing strategic initiatives.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PuraPharm Corp. Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.